Saturday, September 29, 2018

FDA Approves Another Migraine Drug That Might Not Cost A Lot...For Now

  1. FDA Approves Another Migraine Drug That Might Not Cost A Lot...For Now  Newsy
  2. FDA Greenlights Galcanezumab (Emgality) for Migraine Prevention  Medscape
  3. FDA Approves Third Injectable Migraine Drug  Pain News NetworkFull coverage
(CLICK HERE TO READ AND SEE MORE) 

0 comments:

Post a Comment

RSS FeedSUBSCRIBE TO RSS FEED!
FOLLOW US ON TWITTER!Follow us on Twitter!